Cell and Gene Therapy Manufacturing Market
Cell and Gene Therapy Manufacturing Market - Global Industry Assessment & Forecast
#
Pages:
141
Base Year:
2022
Jul - 2023
Format:
Report Code:
VMR-2227
Segments Covered
By
Type Cell Therapy, Gene Therapy
-
By
Indication Oncology Diseases, Inherited Disorders, Cardiovascular Diseases, Musculoskeletal Disorders, Neurological Diseases, Other Indications
-
By
Application Clinical Manufacturing, Commercial Manufacturing
-
By
End User Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations (CMOs), Research Institutes & Academic Centers, Regulatory Agencies, Other End Users
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 4.8 Billion |
 Revenue 2030:
|
USD 15.4 Billion |
 Revenue CAGR
(2023 - 2030): |
18.2% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Cell and Gene Therapy Manufacturing Market Segment Analysis
- Cell and Gene Therapy Manufacturing Type Outlook (Revenue, USD Million, 2018 - 2030)
- Cell Therapy
- Gene Therapy
- Cell and Gene Therapy Manufacturing Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Cell and Gene Therapy Manufacturing Application Outlook (Revenue, USD Million, 2018 - 2030)
- Clinical Manufacturing
- Commercial Manufacturing
- Cell and Gene Therapy Manufacturing End User Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
-
North America Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
-
North America Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
-
North America Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- U.S.
- U.S. Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- U.S. Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- U.S. Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- U.S. Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- U.S. Cell and Gene Therapy Manufacturing Market, by Type
- Canada
- Canada Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Canada Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Canada Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Canada Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Canada Cell and Gene Therapy Manufacturing Market, by Type
-
Mexico
- Mexico Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Mexico Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Mexico Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Mexico Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Mexico Cell and Gene Therapy Manufacturing Market, by Type
-
North America Cell and Gene Therapy Manufacturing Market, by Type
- Europe
-
Europe Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
-
Europe Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
-
Europe Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
-
Europe Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- U. K.
- U.K. Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- U.K. Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- U.K. Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- U.K. Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- U.K. Cell and Gene Therapy Manufacturing Market, by Type
- France
- France Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- France Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- France Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- France Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- France Cell and Gene Therapy Manufacturing Market, by Type
-
Germany
- Germany Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Germany Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Germany Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Germany Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Germany Cell and Gene Therapy Manufacturing Market, by Type
-
Italy
- Italy Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Italy Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Italy Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Italy Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Italy Cell and Gene Therapy Manufacturing Market, by Type
-
Spain
- Spain Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Spain Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Spain Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Spain Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Spain Cell and Gene Therapy Manufacturing Market, by Type
-
Rest of Europe
- Rest of Europe Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Rest of Europe Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Rest of Europe Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Rest of Europe Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Rest of Europe Cell and Gene Therapy Manufacturing Market, by Type
-
Europe Cell and Gene Therapy Manufacturing Market, by Type
- Asia Pacific
-
Asia Pacific Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
-
Asia Pacific Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
-
Asia Pacific Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
-
Asia Pacific Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- China
- China Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- China Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- China Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- China Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- China Cell and Gene Therapy Manufacturing Market, by Type
- Japan
- Japan Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Japan Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Japan Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Japan Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Japan Cell and Gene Therapy Manufacturing Market, by Type
-
Germany
- Germany Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Germany Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Germany Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Germany Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Germany Cell and Gene Therapy Manufacturing Market, by Type
-
India
- India Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- India Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- India Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- India Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- India Cell and Gene Therapy Manufacturing Market, by Type
-
South Korea
- South Korea Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- South Korea Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- South Korea Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- South Korea Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- South Korea Cell and Gene Therapy Manufacturing Market, by Type
-
South East Asia
- South East Asia Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- South East Asia Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- South East Asia Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- South East Asia Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- South East Asia Cell and Gene Therapy Manufacturing Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market, by Type
-
Asia Pacific Cell and Gene Therapy Manufacturing Market, by Type
- Latin America
-
Latin America Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
-
Latin America Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
-
Latin America Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
-
Latin America Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Brazil
- Brazil Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Brazil Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Brazil Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Brazil Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Brazil Cell and Gene Therapy Manufacturing Market, by Type
- Argentina
- Argentina Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Argentina Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Argentina Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Argentina Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Argentina Cell and Gene Therapy Manufacturing Market, by Type
-
Rest of Latin America
- Rest of Latin America Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Rest of Latin America Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Rest of Latin America Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Rest of Latin America Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Rest of Latin America Cell and Gene Therapy Manufacturing Market, by Type
-
Latin America Cell and Gene Therapy Manufacturing Market, by Type
- Middle East & Africa
-
Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
-
Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
-
Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
-
Middle East & Africa Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- GCC Countries
- GCC Countries Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- GCC Countries Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- GCC Countries Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- GCC Countries Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- GCC Countries Cell and Gene Therapy Manufacturing Market, by Type
- South Africa
- South Africa Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- South Africa Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- South Africa Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- South Africa Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- South Africa Cell and Gene Therapy Manufacturing Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Type
- Cell Therapy
- Gene Therapy
- Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Indication
- Oncology Diseases
- Inherited Disorders
- Cardiovascular Diseases
- Musculoskeletal Disorders
- Neurological Diseases
- Other Indications
- Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Application
- Clinical Manufacturing
- Commercial Manufacturing
- Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market, by End User
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Academic Centers
- Regulatory Agencies
- Other End Users
- Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Type
-
Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Type
- North America
Vantage Market
Research | 01-Aug-2023
FAQ
Frequently Asked Question
What is the global demand for Cell and Gene Therapy Manufacturing in terms of revenue?
-
The global Cell and Gene Therapy Manufacturing valued at USD 4.8 Billion in 2022 and is expected to reach USD 15.4 Billion in 2030 growing at a CAGR of 18.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Lonza (Switzerland), Bluebird Bio (U.S.), Catalent Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Samsung Biologics (South Korea), Boehringer Ingelheim (Germany), Cellular Therapeutics (China), Hitachi Chemical Co. Ltd. (Japan), Takara Bio Inc. (Japan), Miltenyi Biotec (U.S.), Thermo Fisher Scientific (U.S.), Novartis International AG (Switzerland), Merck KGaA (Germany), Wuxi Advanced Therapies (U.S.), Fujifilm Holdings Corp. (Japan), Charles River Laboratories International Inc. (U.S.), GE Healthcare Life Sciences (U.S.), CGT Catapult (UK), CoJourney Inc. (China), ElevateBio LLC (U.S.), Pfizer Inc. (U.S.), Incyte Corp. (U.S.), AllogeneTherapeutics Inc. (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 18.2% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cell and Gene Therapy Manufacturing include
- High incidence of cancer and other target diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cell and Gene Therapy Manufacturing in 2022.
